This new EWG, cochaired by Brad Miller, Minneapolis and Faisal Ahmed, Glasgow has the aim of reviewing existing PROs and developing guidance for their use in the field of rhGH therapy. The first meeting of this group was held in March 2025. The EWG also has representation from industry and patient associations.
All EWGs have a Remit and a maximum duration of 2 years.
Current Activities
- Review existing patient-reported outcome (PRO) questionnaires in the field of rhGH therapy
- Develop guidance for the use of PROs in the field of rhGH therapy
Members:
| Brad Miller | Minneapolis, USA |
| Faisal Ahmed | Glasgow, UK |
| Salma Ali | Glasgow, UK |
| Malika Alimussina | Glasgow, UK |
| Ines Alves | ANDO, Portugal |
| Nienke Biermasz | Leiden, Netherlands |
| Ching Chen | Glasgow, UK |
| Ashley Gilmer | ICOSEP, USA |
| Eleanor Grieve | Glasgow, UK |
| Michael Hojby | Novo Nordisk, Denmark |
| Maria Koltowska-Haggstrom | Wroclaw, Poland |
| Mohamad Maghnie | Genoa, Italy |
| Aristides Maniatis | Centennial, USA |
| Julia Quitmann | Hamburg, Germany |
| Caterina Tedesco | Genoa, Italy |
Supported by Project Management Group
Declarations of Interests Table
Members of the PRO EWG can access a private area here
Last Modified